Search research articles
Contact Us
Filters
Showing results (111-120 of 158) with videos related to
Page
of 16
Sort By:
Journal of the American Heart Association
|
November 18, 2016
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial
Barbara E Stähli, Catherine Gebhard, Valérie Duchatelle, et al.
Chest
|
February 26, 2011
Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction
Fatima H Sert Kuniyoshi, Prachi Singh, Apoor S Gami, et al.
The New England Journal of Medicine
|
March 21, 2020
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Frederick J Raal, David Kallend, Kausik K Ray, et al.
The New England Journal of Medicine
|
March 19, 2020
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K Ray, R Scott Wright, David Kallend, et al.
JAMA Cardiology
|
July 27, 2018
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
Stephen J Nicholls, Rishi Puri, Christie M Ballantyne, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 20, 2004
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease
Joseph Murphy, R Scott Wright, Ihor Gussak, et al.
European Heart Journal
|
November 4, 2022
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
Kausik K Ray, Frederick J Raal, David G Kallend, et al.
The New England Journal of Medicine
|
March 18, 2017
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
Kausik K Ray, Ulf Landmesser, Lawrence A Leiter, et al.
Mayo Clinic Proceedings
|
August 19, 2014
A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps
Francisco Lopez-Jimenez, Vinaya Simha, Randal J Thomas, et al.
Journal of the American College of Cardiology
|
March 5, 2021
Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
R Scott Wright, Kausik K Ray, Frederick J Raal, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 158) with videos related to
Sort By:
Page
of 16
Journal of the American Heart Association
|
November 18, 2016
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial
Barbara E Stähli, Catherine Gebhard, Valérie Duchatelle, et al.
Chest
|
February 26, 2011
Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction
Fatima H Sert Kuniyoshi, Prachi Singh, Apoor S Gami, et al.
The New England Journal of Medicine
|
March 21, 2020
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Frederick J Raal, David Kallend, Kausik K Ray, et al.
The New England Journal of Medicine
|
March 19, 2020
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K Ray, R Scott Wright, David Kallend, et al.
JAMA Cardiology
|
July 27, 2018
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
Stephen J Nicholls, Rishi Puri, Christie M Ballantyne, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 20, 2004
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease
Joseph Murphy, R Scott Wright, Ihor Gussak, et al.
European Heart Journal
|
November 4, 2022
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
Kausik K Ray, Frederick J Raal, David G Kallend, et al.
The New England Journal of Medicine
|
March 18, 2017
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
Kausik K Ray, Ulf Landmesser, Lawrence A Leiter, et al.
Mayo Clinic Proceedings
|
August 19, 2014
A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps
Francisco Lopez-Jimenez, Vinaya Simha, Randal J Thomas, et al.
Journal of the American College of Cardiology
|
March 5, 2021
Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
R Scott Wright, Kausik K Ray, Frederick J Raal, et al.
Page
of 16